XBiotech Inc. announced that it has entered into a convertible loan agreement for the gross proceeds of $10 million on January 3, 2024. The loan will have an interest rate of 8%. The loan will be convertible at a conversion price of $4.048 per share.

The transaction will include participation from John Simard, the Company?s Founder, President, Chief Executive Officer and Chairman.